Dysgeusia can result from numerous other causes, including dental disease, oral infections, vitamin deficiencies (particularly zinc and vitamin B12), other medications (such as metronidazole, ACE inhibitors, and certain antibiotics), and systemic conditions such as poorly controlled diabetes itself
Research on GLP-1 specific probiotics suggests that certain strains, particularly Akkermansia muciniphila and specific Lactobacillus and Bifidobacterium species, may support metabolic health outcomes alongside GLP-1 medications
Increased A and neurofibrillary tangle deposition in the brain subsequently promote further cerebrovascular dysfunction via increased ROS production and inflammation (Cheignon et al., 2018)
A meta-analysis focused on complex reproductive histories confirms that for women over 35 with DOR, PCOS, or those undergoing ART cycles, meta-analyses can show meaningful marker improvements, but evidence certainty remains low and effects vary by subgroup and duration
Lower blood pressure, reduced cholesterol levels, and improved blood sugar control are all heart-healthy outcomes of Semaglutide treatment, underscoring its value beyond mere weight loss
There are currently about seventy peptides that have received FDA approval for human use